Comparative in-vitro activity of RP 59500 against clinical bacterial isolates. - Wikidata - awgldk - TriplyDB

Comparative in-vitro activity of RP 59500 against clinical bacterial isolates.

Comparative in-vitro activity of RP 59500 against clinical bacterial isolates.

http://www.wikidata.org/entity/Q44092894

about

Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500 In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci.Combining quinupristin/dalfopristin with other agents for resistant infections.Role of macrolide therapy in chronic obstructive pulmonary disease.Pulsed-field gel electrophoresis analysis of nasopharyngeal flora in children attending a day care center.Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem.Quinupristin/dalfopristin (RP 59500): a new streptogramin antibiotic.

P2860

Q28367434-74870B87-1978-448D-8B86-ED81B4EF7D91 Q35128490-62DEFB16-D86B-48A9-9DFA-5C5B76C4A975 Q35678253-27F11E6B-303B-4708-BDD4-939A6F5E0CC2 Q37319950-F9DE7CD5-E831-470A-991D-2CD09E3CBEF3 Q39455239-E21D3714-031F-44F8-A484-01DD138DB6B8 Q39477058-2BDBF54D-9AEF-4E66-99B0-DC3589B52624 Q41142608-94DF0B11-FBE4-495B-B4CC-6F729BABB1C8

P2860

Comparative in-vitro activity of RP 59500 against clinical bacterial isolates.

http://www.wikidata.org/entity/Q44092894

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年学术文章

@wuu

1992年学术文章

@zh

1992年学术文章

@zh-cn

1992年学术文章

@zh-hans

1992年学术文章

@zh-my

1992年学术文章

@zh-sg

1992年學術文章

@yue

1992年學術文章

@zh-hant

name

Comparative in-vitro activity of RP 59500 against clinical bacterial isolates.

@en

Comparative in-vitro activity of RP 59500 against clinical bacterial isolates.

@nl

type

label

Comparative in-vitro activity of RP 59500 against clinical bacterial isolates.

@en

Comparative in-vitro activity of RP 59500 against clinical bacterial isolates.

@nl

prefLabel

Comparative in-vitro activity of RP 59500 against clinical bacterial isolates.

@en

Comparative in-vitro activity of RP 59500 against clinical bacterial isolates.

@nl

P1433

Q44092894-336E9834-4B65-4B97-B5CA-F27CA520E58E

P1476

Q44092894-2183065B-3185-4891-87FF-3E2A65D9BDBA

P2093

Q44092894-44D0905D-7AC8-44B9-966E-83EB86C8A530

Q44092894-671FD617-FD73-442D-9119-E354D275BAD0

Q44092894-9A16A3DF-8BD4-4929-9295-C90536A41475

Q44092894-BF2BBFCC-A784-4B70-8D93-66C0054DD26B

Q44092894-DC9662D0-EEDA-4A7A-A559-92187320E466

P304

Q44092894-7021623A-6430-4046-B199-F845820E2147

P31

Q44092894-7E35D499-54C1-40E8-B7D1-CFB7EF6520E1

P356

Q44092894-49672463-E002-47C6-9CE3-351AAD1BB647

P407

Q44092894-180DDE58-E789-41AC-ADE1-5C84D89E229C

P478

Q44092894-58BF78BD-63D7-48FE-98EC-BF07DCB6A773

P577

Q44092894-FDD25FEB-CF27-4524-B17F-6818754038B9

P698

Q44092894-FE2491A6-72A8-4A99-BAD3-4D7053CD97F2

P356

P1433

Journal of Antimicrobial Chemotherapy

P1476

Comparative in-vitro activity of RP 59500 against clinical bacterial isolates.

@en

P2093

Inoue K

http://www.w3.org/2001/XMLSchema#string

Inoue M

http://www.w3.org/2001/XMLSchema#string

Mitsuhashi S

http://www.w3.org/2001/XMLSchema#string

Okamoto R

http://www.w3.org/2001/XMLSchema#string

Okubo T

http://www.w3.org/2001/XMLSchema#string

P304

45-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/30.SUPPL_A.45

http://www.w3.org/2001/XMLSchema#string

P407

P478

30 Suppl A

http://www.w3.org/2001/XMLSchema#string

P577

1992-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1399950

http://www.w3.org/2001/XMLSchema#string